See the DrugPatentWatch profile for Fensolvi
What is Fensolvi?
Fensolvi is a brand name for leuprolide (a hormone therapy) in a subcutaneous implant form. It is used for prostate cancer treatment in certain patients, helping lower testosterone levels. [1]
What condition is it approved to treat?
Fensolvi is approved for prostate cancer treatment. Its use is tied to hormone-sensitive or advanced prostate cancer scenarios where lowering testosterone is part of care. [1]
How is Fensolvi given?
Fensolvi is delivered as an implant placed under the skin, rather than a pill or injection you give at home. The prescribing clinician places it as part of treatment. [1]
How does it work?
Because it contains leuprolide, Fensolvi works by affecting the body’s hormone signaling so that testosterone levels drop, which can slow the growth of prostate cancer that depends on androgens. [1]
What are common side effects patients ask about?
Hormone therapies like leuprolide-based products commonly cause effects related to reduced testosterone, such as hot flashes, reduced sex drive, and erectile dysfunction, along with possible injection/implant-site issues. The exact side-effect profile depends on the patient and treatment duration. [1]
Who makes Fensolvi, and where can you find official details?
Official prescribing information and labeling details for Fensolvi are available through regulatory drug databases and the manufacturer’s resources. [1]
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm